153 related articles for article (PubMed ID: 3117676)
1. Enhanced survival of skin grafts depleted of Langerhans' cells by treatment with dimethylbenzanthracene.
Odling KA; Halliday GM; Muller HK
Immunology; 1987 Nov; 62(3):379-85. PubMed ID: 3117676
[TBL] [Abstract][Full Text] [Related]
2. Acceptance of class II major histocompatibility complex disparate skin grafts associated with suppressor cells and elevated Langerhans cell numbers.
Odling KA; Halliday GM; Muller HK
Pathology; 1992 Jul; 24(3):184-9. PubMed ID: 1437291
[TBL] [Abstract][Full Text] [Related]
3. Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.
McMinn PC; Halliday GM; Muller HK
Immunology; 1990 Sep; 71(1):46-51. PubMed ID: 1698716
[TBL] [Abstract][Full Text] [Related]
4. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
Halliday GM; Odling KA; Muller HK
Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
[TBL] [Abstract][Full Text] [Related]
5. Effects of low or high doses of short wavelength ultraviolet light (UVB) on Langerhans cells and skin allograft survival.
Odling KA; Halliday GM; Muller HK
Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():337-43. PubMed ID: 3315985
[TBL] [Abstract][Full Text] [Related]
6. Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts.
Vermeer BJ; Santerse B; Van De Kerckhove BA; Schothorst AA; Claas FH
Transplantation; 1988 Mar; 45(3):607-10. PubMed ID: 3126570
[TBL] [Abstract][Full Text] [Related]
7. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
8. Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion.
Woods GM; Qu M; Ragg SJ; Muller HK
Immunology; 1996 May; 88(1):134-9. PubMed ID: 8707340
[TBL] [Abstract][Full Text] [Related]
9. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival of cultured keratinocyte allografts in the nonimmunosuppressed mouse.
Hammond EJ; Ng RL; Stanley MA; Munro AJ
Transplantation; 1987 Jul; 44(1):106-12. PubMed ID: 3299909
[TBL] [Abstract][Full Text] [Related]
11. Suppressor cell activation and enhanced skin allograft survival after tumor promotor but not initiator induced depletion of cutaneous Langerhans cells.
Halliday GM; Odling KA; Ruby JC; Muller HK
J Invest Dermatol; 1988 Mar; 90(3):293-7. PubMed ID: 2964490
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of skin allograft survival in H-2 K and I region-incompatible mice by pretransplant blood transfusion.
Okazaki H; Maki T; Wood ML; Jones S; Monaco AP
Transplantation; 1981 Aug; 32(2):111-5. PubMed ID: 7027546
[TBL] [Abstract][Full Text] [Related]
13. Carcinogen-induced depletion of cutaneous Langerhans cells.
Muller HK; Halliday GM; Knight BA
Br J Cancer; 1985 Jul; 52(1):81-5. PubMed ID: 3925975
[TBL] [Abstract][Full Text] [Related]
14. Immunological unresponsiveness induced by ultraviolet-B-irradiated and nonirradiated skin grafts.
Vandekerckhove BA; Datema G; Claas FH
Transplantation; 1990 Mar; 49(3):596-9. PubMed ID: 2316019
[TBL] [Abstract][Full Text] [Related]
15. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
Mayumi H; Good RA
Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
[TBL] [Abstract][Full Text] [Related]
16. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
17. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice.
RodrÃguez-Barbosa JI; Haller GW; Zhao G; Sachs DH; Sykes M
Transpl Immunol; 2005 Oct; 15(1):25-33. PubMed ID: 16223670
[TBL] [Abstract][Full Text] [Related]
18. Influence of ultraviolet radiation treatment on the survival of heterotopic skin grafts in the mouse.
Claas FH; Rothert M; Havinga I; Schothorst AA; Vermeer BJ; van Rood JJ
J Invest Dermatol; 1985 Jan; 84(1):31-2. PubMed ID: 3880794
[TBL] [Abstract][Full Text] [Related]
19. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
